News from aurigene discovery technologies limited
A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages
31 Mar, 2017, 07:09 BST Aurigene to Present its Programs on Covalent, Selective CDK7 Inhibitors, Novel Peptide Antagonists of CD47-SIRPα Interaction and Inhibitors of MALT-1 Signalling at the AACR 2017
Aurigene will present data for its: Proprietary novel, first-in-class, peptide antagonists of CD47-SIRPα interaction program which is currently in...
11 Oct, 2016, 13:46 BST Aurigene Announces the Exercise of Curis' Option for CA-327 (PD-L1/TIM-3 Small Molecule Antagonist), The Third Program Under Its Collaboration, License and Option Agreement of January, 2015 (October 11, 2016, New Jersey, NJ, USA)
Aurigene, a discovery stage biotechnology company developing novel and best-in-class therapies to treat cancer and inflammatory diseases, announced...